This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human CD163 DuoSet ELISA
catalog :
DY1607-05
quantity :
1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
price :
440 USD
citations: 29
Reference
Williams M, Asia L, Lindeque Z, Jansen van Vuren E. The association between HIV-1 Tat and Vif amino acid sequence variation, inflammation and Trp-Kyn metabolism: an exploratory investigation. BMC Infect Dis. 2024;24:943 pubmed publisher
Grannes H, Ueland T, Simeone P, Liani R, Guagnano M, Aukrust P, et al. Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus. Cardiovasc Diabetol. 2024;23:146 pubmed publisher
Evans C, Mutasa K, Rukobo S, Govha M, Mushayanembwa P, Chasekwa B, et al. Inflammation and cytomegalovirus viremia during pregnancy drive sex-differentiated differences in mortality and immune development in HIV-exposed infants. Nat Commun. 2024;15:2909 pubmed publisher
Giron L, Liu Q, Adeniji O, Yin X, Kannan T, Ding J, et al. Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection. Nat Commun. 2024;15:3035 pubmed publisher
Li J, Melberg M, Kittilson A, Abdel Mohsen M, Li Y, Aga E, et al. Predictors of HIV rebound differ by timing of antiretroviral therapy initiation. JCI Insight. 2024;9: pubmed publisher
Giron L, Liu Q, Adeniji O, Yin X, Kannan T, Ding J, et al. Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection. bioRxiv. 2023;: pubmed publisher
Ackermann M, Kamp J, Werlein C, Walsh C, Stark H, Prade V, et al. The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling. EBioMedicine. 2022;85:104296 pubmed publisher
Kared H, Wolf A, Alirezaylavasani A, Ravussin A, Solum G, Tran T, et al. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults. Nat Commun. 2022;13:4165 pubmed publisher
Cairoli V, De Matteo E, Casciato P, Ameigeiras B, Preciado M, Valva P. The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects. PLoS ONE. 2022;17:e0270911 pubmed publisher
da Silva Prata R, Mendes M, Soares V, Fran xe7 a Costa J, Sales A, Duppr xe9 N, et al. Arginase 1 is a marker of protection against illness in contacts of leprosy patients. Sci Rep. 2022;12:7850 pubmed publisher
Maeno H, Wong P, AbuBakar S, Yang M, Sam S, Jamil Abd J, et al. A 3D Microfluidic ELISA for the Detection of Severe Dengue: Sensitivity Improvement and Vroman Effect Amelioration by EDC-NHS Surface Modification. Micromachines (Basel). 2021;12: pubmed publisher
Kelly C, Tinago W, Alber D, Hunter P, Luckhurst N, Connolly J, et al. Inflammatory pathways amongst people living with HIV in Malawi differ according to socioeconomic status. PLoS ONE. 2021;16:e0256576 pubmed publisher
Pihlstrøm H, Ueland T, Michelsen A, Aukrust P, Gatti F, Hammarstrom C, et al. Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients. PLoS ONE. 2020;15:e0243759 pubmed publisher
Novelli S, Lécuroux C, Goujard C, Reynes J, Villemant A, Blum L, et al. Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection. EBioMedicine. 2020;62:103129 pubmed publisher
Vujkovic Cvijin I, Sortino O, Verheij E, Sklar J, Wit F, Kootstra N, et al. HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases. Nat Commun. 2020;11:2448 pubmed publisher
Ruíz Plazas X, Rodríguez Gallego E, Alves M, Altuna Coy A, Lozano Bartolomé J, Portero Otín M, et al. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness. J Transl Med. 2019;17:307 pubmed publisher
Dereke J, Nilsson J, Nilsson C, Strevens H, Landin Olsson M, Hillman M. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance. PLoS ONE. 2019;14:e0216728 pubmed publisher
Gualdoni G, Hofmann G, Wohlfarth P, Winkler H, Winkler S, Haslacher H, et al. Prevalence and Outcome of Secondary Hemophagocytic Lymphohistiocytosis Among SIRS Patients: Results from a Prospective Cohort Study. J Clin Med. 2019;8: pubmed publisher
Foo S, Chen W, Chan Y, Lee W, Lee S, Cheng G, et al. Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight. 2018;3: pubmed publisher
Espíndola M, Soares L, Galvão Lima L, Zambuzi F, Cacemiro M, Brauer V, et al. Epigenetic alterations are associated with monocyte immune dysfunctions in HIV-1 infection. Sci Rep. 2018;8:5505 pubmed publisher
Dekkema G, Abdulahad W, Bijma T, Moran S, Ryan L, Little M, et al. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study. Nephrol Dial Transplant. 2019;34:234-242 pubmed publisher
Cheret A, Durier C, Melard A, Ploquin M, Heitzmann J, Lécuroux C, et al. Impact of early cART on HIV blood and semen compartments at the time of primary infection. PLoS ONE. 2017;12:e0180191 pubmed publisher
Booiman T, Wit F, Maurer I, De Francesco D, Sabin C, Harskamp A, et al. High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid. Open Forum Infect Dis. 2017;4:ofx108 pubmed publisher
Ueland T, Laugsand L, Vatten L, Janszky I, Platou C, Michelsen A, et al. Monocyte/macrophage and T cell activation markers are not independently associated with MI risk in healthy individuals - results from the HUNT Study. Int J Cardiol. 2017;243:502-504 pubmed publisher
Samuelsson M, Dereke J, Svensson M, Landin Olsson M, Hillman M. Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study. Diabetol Metab Syndr. 2017;9:41 pubmed publisher
Zambuzi F, Cardoso Silva P, Espíndola M, Soares L, Galvão Lima L, Brauer V, et al. Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis. Cytokine. 2016;88:99-107 pubmed publisher
Ploquin M, Madec Y, Casrouge A, Huot N, Passaes C, Lécuroux C, et al. Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset. PLoS Pathog. 2016;12:e1005774 pubmed publisher
Gram M, Anderson U, Johansson M, Edström Hägerwall A, Larsson I, Jälmby M, et al. The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators. PLoS ONE. 2015;10:e0138111 pubmed publisher
Rojo Martinez G, Maymó Masip E, Rodriguez M, Solano E, Goday A, Soriguer F, et al. Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study. PLoS ONE. 2014;9:e101250 pubmed publisher
product information
master code :
DY1607
SKU :
DY1607-05
product name :
Human CD163 DuoSet ELISA
unit size :
1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
description :
The Human CD163 DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human CD163.
target :
CD163
category :
ELISAs
species :
Human
gene symbol :
CD163
kit type :
Solid Phase Sandwich ELISA
elisaRange :
156.00 - 10000 pg/mL
top caption :
Human CD163 ELISA Standard Curve
applications :
ELISA
USD :
440 USD
alt names :
CD_antigen: CD163, CD163, CD163 molecule, GHI/61, HbSR, Hemoglobin scavenger receptor, M130, macrophage-associated antigen, MM130, RM3/1, SCARI1, scavenger receptor cysteine-rich type 1 protein M130, sCD163, Soluble CD163
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.